NAD Has ‘High Hopes’ Firms Cooperate On Schedules To Accelerate Reviews
This article was originally published in The Tan Sheet
Executive Summary
The National Advertising Division changes its review process to allow opposing firms some control over scheduling in the process and in resolving their disputes. The changes, recommended by ABA committees, also impose fees for both firms in appeals and allow more time for compliance with decisions.
You may also be interested in...
Flonase Ad Claims Settlement Confidential, But McNeil Likely Gains Choosing Court Over NAD
When prompt action is a primary goal, as McNeil aimed for in challenging ad claims for Glaxo’s Flonase Allergy Relief, lawyers say going to court is a better option than going to the National Advertising Division. Even with allegations that wither under the opposing firm’s rebuttal, litigation of advertising complaints it gains publicity than a NAD review would generate.
MoCRA Stakeholders Reminded Registration Enforcement Begins 1 July: ‘Do Not Delay!’
The Independent Beauty Association urged stakeholders at its Cosmetic Convergence Symposium to take action to ensure they are meeting requirements of the Modernization of Cosmetics Regulation Act come 1 July, when FDA’s enforcement of the facility and product registration deadline begins. Presenters offered tips from companies that have already completed the process.
Cosmetics Industry Awaits FDA’s Allergen List While Working To Inform GMP Rulemaking
The Independent Beauty Association does not yet have insight into what ingredients will be listed in the US FDA’s proposed rulemaking for cosmetic allergen labeling – due by 29 June – but is optimistic the agency will consult industry when it comes to setting the compliance timeline. Meanwhile, industry stakeholders are pushing for international harmonization in the agency’s cosmetic GMPs rulemaking.